Baxter International revenue was $11.67 b in FY, 2020
Baxter International revenue breakdown by business segment: 7.7% from Advanced Surgery, 7.7% from Clinical Nutrition, 19.0% from Pharmaceuticals, 24.6% from Medication Delivery, 32.0% from Renal Care and 9.0% from Other
Baxter International revenue breakdown by geographic segment: 53.6% from Americas, 26.1% from EMEA and 20.2% from APAC
FY, 2019 | FY, 2018 | FY, 2017 | |
---|---|---|---|
Other | $485 m | $510 m | $455 m |
Acute Therapies | $535 m | $517 m | $456 m |
Advanced Surgery | $877 m | $800 m | $707 m |
Clinical Nutrition | $872 m | $877 m | $882 m |
Pharmaceuticals | $2.16 b | $2.09 b | $1.88 b |
Medication Delivery | $2.8 b | $2.67 b | $2.7 b |
Renal Care | $3.64 b | $3.66 b | $3.48 b |
FY, 2019 | FY, 2018 | FY, 2017 | |
---|---|---|---|
Americas | $6.09 b | $5.96 b | $5.72 b |
EMEA | $2.97 b | $2.96 b | $2.73 b |
APAC | $2.3 b | $2.21 b | $2.11 b |
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.